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Epithelia and endothelia separate different tissue compartments and protect multicellular 
organisms form the outside world. This requires the formation of tight junctions, selective 
gates that control paracellular diffusion of ions and solutes. Tight junctions also form the 
border between the apical and basolateral plasma membrane domains and are linked to the 
machinery that controls apicobasal polarization. Additionally, signalling networks that 
guide diverse cell behaviours and functions are connected to tight junctions, transmitting 
information to and from the cytoskeleton, nucleus and different cell adhesion complexes. 
Here, we discuss recent advances in our understanding of the molecular architecture and 
cellular functions of tight junctions.   
 
 Microscopists in the 19th century described the paracellular space between neighbouring cells 
within an epithelial sheet to be sealed by a “terminal bar”, a structure later resolved by electron 
microscopy into a composite of distinct cell-cell junctions that is now called the epithelial junctional 
complex and is formed by tight junctions, adherens junctions and desmosomes1,2.	  As the former 
two junctions are more tightly associated and often reside at the apical end of the lateral 
membrane, they are often referred to as the apical junctional complex (however, in endothelia, tight 
junctions and adherens junctions can be intercalated) (Fig. 1). Tight junctions are essential for 
barrier formation, and their primary physiological role is to function as paracellular gates that 
restrict diffusion on the basis of size and charge. Selective paracellular diffusion is an essential 
process for the maintenance of homoeostasis in organs and tissues. Tight junctions have long 
been the most enigmatic of all adhesion complexes and eluded a detailed molecular and functional 
analysis due to their complex architecture. Recent years have witnessed the identification of a 
large array of components associated with tight junctions implicating these junctions in an 
unexpected range of different functions, thereby challenging the traditional model, in which tight 
junctions are considered a simple diffusion barrier formed by a rigid molecular complex. In line with 
these various functions, mutations in genes encoding tight junction proteins have been linked to a 
range of inherited human diseases. Additionally, tight junction components are known to be 
targeted by a number of pathogenic bacteria and viruses, which hijack tight junction proteins to 
enter and infect cells, or target junctional signalling mechanisms to cross tissue barriers.  Although 
tight junctions are a vertebrate junction, many of their components and functions are evolutionarily 
conserved (Box 1).  
 The main purpose of this review is to examine the recent advances in the unravelling of the 
molecular architecture of tight junctions and understanding their functions. We will discuss recent 
exciting insights into how tight junctions function as signalling platforms that guide cell behaviour 
and differentiation, as well as their role in cell polarization. We will also survey recent results 
suggesting unexpected crosstalk between tight junctions and other adhesive structures. 
 
Structure and composition 
 Electron microscopy revealed that tight junctions form very close focal contacts between plasma 
membranes of neighbouring cells that, depending on the preservation method used, may appear 
as apparent hemifusions or “kisses”2	  (Fig. 1). By freeze fracture electron microscopy, a technique 
that enables the imaging of the hydrophobic interior of a membrane, tight junctions appear as 
meshwork of fibrils, often apparently formed by rows of transmembrane particles, that are thought 
to represent the diffusion barriers3,4.	  Tight junctions also contain an electron dense junctional 
plaque that consists of cytosolic proteins that form the interface between the junctional membrane 
and the cytoskeleton. 
 
 
 
 
	  
3	  
	  
Transmembrane proteins 
 The main protein components of the transmembrane strands observed by freeze fracture 
electron microscopy are tetraspan proteins of the claudin family (encompassing 26 members in 
humans and 27 in mouse, see below) and the three junctional MARVEL domain proteins: occludin, 
tricellulin and MarvelD3. Although not confirmed for all members of the two families, these proteins 
have been localised by immunoelectron microscopy to the strands and shown to induce 
superficially similar strands if expressed in cells that do not form tight junctions in the case of 
claudins or transmembrane particles and short strand fragments in the case of occludin 5-8. 
Similarly, some claudins and occludin are able to mediate Ca-independent cell-cell adhesion, 
further supporting a model in which tight junctions consist of multimeric transmembrane protein 
complexes that mediate cell-cell adhesion8,9. 
 Other transmembrane components of tight junctions include a trispan protein, BVES (blood 
vessel epicardial substance), and a large group of single span transmembrane adhesion proteins 
with two immunoglobulin like domains that comprises junctional adhesion proteins (JAMs), 
Coxsakie adenovirus receptor (CAR), and angulins (or lipolysis-stimulated lipoprotein receptors)10-
15. Angulins, together with tricellulin, are enriched in tricellular corners and are thought to mediate 
functional integrity of the junction in epithelial and endothelial cells. Additionally, Crb3, a protein 
with EGF like domains important for apical polarization, associates with tight junctions16,17. These 
proteins have not been shown to associate with the transmembrane strands but can modulate the 
strength of the junctional barrier if removed or overexpressed, or, like JAM proteins, regulate 
junction assembly (see below). Many of the functions of transmembrane tight junction proteins 
depend on interactions with components of the complex cytosolic plaque that lines the junctional 
membrane. 
 
Junctional plaque components 
 The cytosolic plaque is a complex protein network that interacts with the cytoplasmic domains of 
junctional membrane proteins as well as with the F-actin and tubulin cytoskeleton (Fig. 1B). Its 
main structural components are adaptor proteins that contain multiple protein/protein interaction 
motifs18. A typical example is the first tight junction protein identified, ZO-1 (zonula occludens-1), a 
220kDa peripheral membrane protein, consisting of an N-terminal half with three PDZ (PSD-95, 
DlgA, ZO-1 homology) domains, an SH3 (Src homology 3) domain, and a GUK (yeast guanylate 
kinase homology domain); whereas its C-terminal half interacts with F-actin and contains 
alternatively spliced domains that may confer tissue-specific functions 19-21. The N-terminal motifs 
bind to different transmembrane proteins: claudins via the first PDZ domain, JAMs via the third and 
occludin via the GUK domain. The SH3 domain links ZO-1 to junctional signalling mechanisms by 
binding to ZONAB (see below), a transcriptional and posttranscriptional regulator of gene 
expression, and Apg-2, a heat shock protein	  20,22-­‐25. ZO-1 also engages in intramolecular 
interactions that lead to a closed conformation in which access to the central GUK/SH3 module is 
limited26,27. A feature that may also underlie the inability of in vitro translated full length ZO-1 to bind 
SH3 domain ligands that bind to shorter domain constructs28. Although the functional relevance of 
such intramolecular interactions is poorly understood, they may serve as regulatory switches for 
ligand binding and, thereby, junction formation and signalling.  
 The tight junction plaque contains a vast number of such adaptor proteins, many interacting 
with each other, forming a protein network. Examples include ZO-2 and ZO-3 two proteins that co-
immunoproecipitate with ZO-129-31. They have the same domain structure as ZO-1 within the N-
terminal half but have unique C-terminal parts. ZO-1 and ZO-2 interact with ZO-1 in a mutually 
exclusive manner via the second PDZ domain. Other examples are the MAGI proteins, which have 
the same type of domains as the ZO proteins but in an inverted arrangement, or the multi-PDZ 
domain proteins MUPP1 and PATJ	  32-­‐36. Another type of junctional adaptor is represented by 
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cingulin and JACOP/paracingulin, two homologous coiled-coil proteins that bind to a variety of 
different junctional proteins, including F-actin and, in the case of cingulin, microtubules37,38. The 
cytoplasmic plaque may be an ordered structure with proteins like cingulin being farther from the 
membrane than core proteins like ZO-1 (Fig. 1C)	  39. Although such proteins may have a distinct 
overall distribution within the junction, their distributions overlap and they are able to interact with 
each other and form complexes40. The junction also contains many different signalling proteins that 
are recruited by binding to adaptors or to membrane proteins such as occludin and MarvelD341,42.	  
This includes protein kinases, phosphatases, monomeric and trimeric GTP-binding proteins and 
transcriptional and post-transcriptional regulators, which participate in various signalling pathways 
(Table 1)43-45. 
 The number of junctional proteins, many of which belonging to the same protein family or 
having similar protein binding motifs, is intriguing. While the many claudins can be explained by 
their different functional properties, it is more difficult to understand why so many adaptor proteins 
are required. Knockouts and knockdowns in cells in culture or whole organisms yielded often only 
minimal functional consequences (e.g., cingulin, ZO-3)46,47. Hence, many junctional proteins are 
considered to have redundant functions. However, this is surely not the case for ZO-1 and ZO-2, 
as individual knockouts of both adaptors are embryonic lethal48,49. Even in vitro, the lack of a clear 
phenotype in loss of function experiments studying ZO-1 in MDCK cells was later attributed to 
incomplete depletion in some RNA interference studies as reexpression of ZO-1 at low levels in 
knockout cells could rescue the phenotype50. Nevertheless, adaptive processes in the junctional 
protein network in response to removal of individual components do occur. For example, deletion 
of ZO-3 in mice leads to increased junctional recruitment of ZO-246. Such adaptive processes 
render junctions biologically more robust, but they make experimental analysis more difficult as, for 
example, constitutive depletion methods in cell lines may lead to adaptive processes during cell 
line selection. The apparent redundancy under standard experimental conditions may also mean 
that a protein is only important under certain conditions or in specific cell types and/or model 
systems, as exemplified by the importance of ZO-3 for osmoregulation in zebrafish or occludin for 
barrier maintenance in ethanol-stressed mice51,52. Hence, understanding the functional role of 
specific tight junction proteins and how they cooperate to form functional junctional complexes will 
require a more detailed analysis of specific tissues and processes in different experimental models, 
conditional gene inactivation approaches, overexpression experiments, and analysis of how 
junctional complexes adapt to removal of specific components.  
 
Models of tight junction structure  
 The ultrastructural appearance of tight junctions has stimulated the discussion about their 
molecular architecture for decades. Two models have emerged: a protein model and a protein/lipid 
hybrid model; the latter is often referred to as the lipid model, although the need for proteins had 
always been accepted (Fig. 2A). The protein model posits that the paracellular diffusion barrier is 
formed by transmembrane proteins that form an intercellular protein complex between the two 
neighbouring plasma membranes that have a standard bilayer lipid configuration. This model has 
recently gained more support due to the identification of the claudin crystal structure and 
subsequent modelling approaches that enabled the construction of a model that provides a good fit 
to the junctional ultrastructure. The 2.4Å resolution structure of claudin-15 revealed a characteristic 
β-sheet fold formed by the two extracellular domains, which are anchored to a transmembrane 
four-helix bundle (Fig. 3)53. Claudin-15 forms a linear polymer mediated by specific interactions 
between adjacent extracellular domains that are required for reconstituting tight junction-like 
intramembrane strands. Cysteine crosslinking then led to a model in which two such anti-parallel 
strands associate with each other to form an intramembrane tight junction-strand54. Consequently, 
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each membrane-membrane contact site consists of four claudin polymers, two per cell, that 
interact via their extracellular domains, forming the junctional barrier and permeation pathway. As 
different claudins may either polymerize within the same strand or adjacent strands in a heterotypic 
or homotypic fashion, tight junction strands form a mosaic consisting of various claudin 
molecules55-57. While this model provides a possible structural explanation for how claudins may 
form linear strands, it is more difficult to see how other junctional membrane proteins that associate 
with strands (e.g., occludin) and have different dynamic properties fit into this model58. Similarly, 
native junctional intramembrane strands are not linear but anastomose, leading to the formation of 
networks (Fig. 1E). Hence, a molecular model for strand formation requires a mechanism for 
branching.  
 The hybrid model offers possible answers to some of these questions. It proposes that the close 
membrane-membrane contact sites are actual membrane hemifusions and that the intramembrane 
strands are cylinders of inverted lipid micelles. In this case, the lamellar structure of the membrane 
lipid bi-layer forms a hexagonal transitory arrangement whereby lipid chains are oriented outwards 
(Fig. 2A)59,60.	  This model is based on the demonstration that protein-free liposomes can form tight 
junction-like strands61. A hemifusion state is energetically unfavourable; hence, transmembrane 
proteins were proposed to stabilise the inverted micellar structure59. This model is supported by the 
observation that native tight junction strands seem to contain protein and phospholipids62,63. 
According to this model, lipids are filling the gaps between different types of membrane proteins, 
eliminating the need of proteins forming continuous polymers58,64. Consequently, this model 
enables to explain why different protein components that have different dynamic properties can be 
a part of the same strands. 
 Different experiments have been performed to differentiate between the two models, but a 
consensus was not reached. Cell-to-cell lipid diffusion experiments should provide an answer as 
lipids can only diffuse from one cell to another if the exoplasmic leaflet of two neighbouring cells is 
continuous as in the hybrid model. However, lipids with large polar heads did not diffuse whereas 
fluorescently labelled lipids with modified acyl chains did65,66. It is thus possible that alternative 
barriers prevent diffusion of lipids with large head domains (e.g., the negative membrane 
curvature) or that the modified lipid exchanges between closely apposed membranes. Regardless 
of the model, lipids are important for tight junctions. For example, some tight junction proteins are 
associated with cholesterol-rich, detergent-resistant membrane microdomains and modification of 
cholesterol modifies epithelial barrier properties67-69. However, freeze-fracture analysis of tight 
junctions of cholesterol depleted cells yielded contradictory results, and cholesterol may affect a 
membrane by influencing the lipid structure or the functional properties of transmembrane proteins 
by altering their lipid environment 70,71. Finally, one could also imagine that the strands are not as 
homogenous as generally assumed and might be composed of sections containing different lipid 
structures and protein composition.  
 The true structure of tight junctions thus remains to be established. As intramembrane strands 
can thus far only be seen in fixed specimen, new methods will have to be developed that enable 
visualization of strand dynamics. Hopefully, improvements of live imaging approaches combined 
with enhanced resolution of light microscopy may provide the key to answer these questions. 
Nevertheless, the current models and structural data allow us to gain a better understanding of 
how tight junctions function as permeability barriers.  
 
Barrier functions 
 Tight junctions form two types of barriers: a paracellular one that regulates selective paracellular 
permeability and an intramembrane one that restricts exchange of membrane components 
between the apical and basolateral cell surface domains (Fig. 2B). The two barriers have the same 
physical location at intramembrane strands and are likely to be structurally related.    
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Regulation of paracellular permeability  
 The physiological properties of the junctional gate are that of a semipermeable diffusion barrier 
that discriminates solutes on the basis of size and charge72. Solutes can cross the junctional 
paracellular pathway along two routes. A charge-selective permeation pathway that is thought to 
consist of pores across serially arranged barriers allowing diffusion of ions and small uncharged 
molecules (Fig. 2C). These pores have a diameter of ~4-8Å depending tissue and molecule 
analysed73-75.  A second diffusion pathway allows the diffusion of larger solutes, macromolecules 
up to a size limit of ~30-60Å72,75. Charge-selective ion permeation and size-selective 
macromolecular diffusion occur by different mechanisms and can be regulated in opposing 
manners76. Ion permeation is typically measured by assessing electrical resistance or conductivity, 
an instantaneous measurement that requires a continuous conductive pathway for a current to 
flow. Macromolecular diffusion is slow, requires tracer diffusion measurements over longer periods 
of time (i.e., hours), and, hence, may occur in a stepwise manner (Fig. 2D). To explain charge-
selective permeation, a model of the junction evolved that considers the intramembrane strands to 
contain regulated ion-selective channels that can open and close. To account for macromolecular 
permeation a dynamic strand model has been introduced, in which the intramembrane strands 
remodel, allowing slow, diffusion (Fig. 2D). Such serial diffusion barriers might be formed by 
protein polymers according to the protein model or, alternatively, inverted lipid cylinders whose 
stability is regulated by associated proteins76. In this model, the size-selectivity would be 
determined by the distance between the outer leaflets of the two adhering plasma membranes. In 
an alternative model, tight junctions were proposed to be formed by two differently sized inverted 
micelles and macromolecular diffusion to occur inside the larger ones that dynamically form and 
dissolve75. However, current freeze fracture data does not suggest that junctions contain two 
different sizes of intramembrane strands. 
 While significant progress has been made in the elucidation of the molecular mechanisms that 
enable junctional ion permeability, macromolecular diffusion is still not well understood and 
currently available insights have been summarized in other reviews75,76. Hence, we will focus here 
on recent exciting findings deciphering the molecular mechanisms underlying junctional ion 
permeation. 
 
 Upon their discovery, claudins quickly emerged as candidates for mediating ion-selective 
paracellular diffusion, as one of them, claudin-16 (paracellin-1) was identified as a gene mutated in 
renal magnesium wasting, an inherited disease affecting renal paracellular magnesium 
reabsorption (Box 2)77. Claudins' tissue-specific expression pattern further fuelled the hypothesis 
that the claudin composition of a tight junction determines the permeability properties. Claudins are 
now grouped according to their channel- and barrier-forming properties into those that support 
cation-selectivity (e.g. claudin-2, 10b, 15), anion-selectivity (e.g. claudin-10a, 17), or preferentially 
sealing claudins (e.g., claudin-1)73,78-85. The latter group are claudins that have not (yet) been 
associated with promoting permeability of a specific type of ion or molecule, and are hence thought 
to enhance the barrier function. However, it is also possible that they form pores for yet to be 
identified molecules.  
 Expression studies combined with measuring permeability of epithelial cell monolayers 
demonstrated that claudins are important determinants of the paracellular barrier properties. First 
evidence for channel formation came from structural and functional studies demonstrating that 
modification of the first extracellular loop of claudins affects the conductive properties of claudin-
transfected cells85,86. For example, the cation-selective claudin-2 contains a critical residue in its 
first extracellular loop that, if replaced with a cysteine followed by modification with the thiol-
reactive bulky reagent methanethiosulfonate was found to block the ion-conductive pathway87,88. 
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More direct evidence came from a recent patch clamp approach demonstrating that claudin-2 
indeed forms a gated cation-selective paracellular pore89.  
 The recent x-ray crystal structure of claudin-15, a cation-selective claudin, provides a possible 
structural basis to explain the formation of ion-selective channels 53,54,90,91. According to the model 
proposed, a characteristic anti-parallel β-sheet fold formed by the first extracellular loop and the C-
terminal end of the second extracellular loop is anchored to a conserved transmembrane four-helix 
bundle (Fig. 3A). Apart from segment 3, the length of the transmembrane domains is consistent 
with the lipid bilayer thickness and they contain residues with small side chains that are important 
for tight helical packing. Mutations leading to changes in such residues are associated with human 
disease, suggesting that they are indeed important77,92. Similarly, mutation of the two conserved 
cysteine residues in extracellular loop 1 abolishes the barrier forming ability of claudin-5, 
suggesting that the disulfite bond is important to stabilise the β-sheet structure93. Head-to-head 
association of two antiparallel claudin strands from one cell with two strands from the neighbouring 
cell is thought to lead to the formation of a β-barrel that defines the paracellular pore (Fig. 3B,C)54. 
Other authors have expressed reservations about the packing density generated by such a 
structure94. However, the β-barrel model is compatible with structure-function studies performed 
previously. For example, the negatively charged residues Glu55 and Asp64 of claudin-15 extend 
away from the β-sheet surface, leading to a negatively charged β-barrel, which would be 
compatible with a cation-selective pore. Previous work indeed demonstrated that substituting these 
two residues by positively charged ones alters ion-selectivity of this claudin86. Similarly, homology 
models indicate that cation-selective and anion-selective claudins-2 and -10a form negatively and 
positively charged barrel surfaces, respectively53. Altogether, this β-barrel model provides an 
excellent base for future work to elucidate the structural basis for junctional ion permeation.  
 Patch clamp experiments indicate that the junctional pores are gated, but the structural basis for 
opening and closing has not been analysed89. Gating might be regulated by mechanisms that are 
yet to be identified. An interesting paradigm is provided by WNK1 and WNK4, two kinases linked to 
Pseudohypoaldosteronism type II, an autosomal dominant disorder that leads to hypertension. 
WNK4 localises to tight junctions and expression of disease-causing alleles of the two kinases 
stimulates phosphorylation of multiple claudins and leads to increased chloride permeability95-99. 
While these studies indicate that claudin-mediated ion conductance is regulated, the structural 
changes that lead form phosphorylation of claudins to opening claudin-based pores remain to be 
determined. 
 
Intramembrane diffusion barrier: the fence function 
 The junctional fence has been defined by diffusion experiments with fluorescent lipid probes 
and lipids that demonstrated that a diffusion barrier restricts intermixing of apical and basolateral 
lipids in the exoplasmic plasma membrane leaflets (Fig. 2B)100,101. Although not directly 
demonstrated, based on these properties one would assume tight junctions also act as a fence for 
transmembrane proteins. The fence function is assumed to be linked to the intramembrane strands 
as experimental manipulations that do or do not affect their integrity often have analogous effects 
on integrity of the junctional fence. For example, transient ATP depletion in MDCK cells has no 
effect on the fence function and the suprastructure of tight junctions but, for unknown reasons, 
leads to disruption of the paracellular diffusion barrier102. In contrast, treatment of epithelial cells 
with a rotavirus derived peptide leads to a partial disruption of the continuous intramembrane 
strand network and increased lipid diffusion between apical and basolateral plasma membrane 
domains103. In the protein model, the transmembrane proteins forming the strands serve to restrict 
intramembrane diffusion; whereas in the hybrid model, apical and basolateral membrane leaflets 
are discontinuous, inherently generating an exoplasmic fence. However, also here one would 
expect transmembrane proteins to play a role, as the unconventional lipid structures of the hybrid 
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model require stabilisation (Fig. 2A). Expression of an occludin mutant with inactivated cytosolic 
domains that is unable to interact with the cytoplasmic plaque indeed disrupts the lipid diffusion 
barrier104. It does so without disrupting the network of intramembrane strands, arguing against a 
model in which the strands act as the diffusion fence. As this mutant form of occludin also results in 
increased macromolecular paracellular diffusion, it is possible that the fence function and the 
mechanism enabling macromolecular diffusion are related. According to the dynamic strand model, 
intramembrane strands remodel to allow macromolecular diffusion (Fig. 2D). If the strands were 
responsible for the fence function as well, increased strand dynamics would indeed lead to 
increased intramembrane and macromolecular diffusion. Testing such a model will require the 
development of approaches to visualise both lipid diffusion and intramembrane strand dynamics in 
live cells.  
 The overall importance of the fence for maintaining epithelial polarity is often overestimated as 
cells that have a defective junctional fence due to expression of mutant form of occludin still 
polarize104. Even cells that lack tight junctions due to combined removal of ZO-1 and ZO-2 still 
polarize and maintain at least some polarized lipid distribution105,106. It remains thus to be 
established to what extent the fence function is physiologically required for functional epithelia. 
 
Assembly and links to apical polarity 
 Establishment of tight junctions is a multistep process that involves an array of distinct signalling 
mechanisms that guide and control this process, and ultimately leads to cell surface polarization 
and the differentiation of often organ-specific apical domains, such as the intestinal brush border 
membrane.  
 
Tight junction assembly  
 Tight junction assembly is commonly studied in Ca-switch models in which cells are plated on a 
filter, enabling transepithelial measurements for barrier formation, in a medium with a low calcium 
concentration that does not allow junction formation, which is then induced by adding additional 
calcium107,108. Such experiments demonstrated that tight and adherens junctions are not 
morphologically well-defined during early junction assembly but resemble the primordial junctional 
complexes observed in primitive nematodes and lie within the same plane as the basal, focal 
adhesion complex (Fig. 4A). The close relationship between tight and adherens junctions is 
reflected in biochemical interactions between core components of these junctions. For instance, 
ZO-1 and α-catenin, a protein that links adherens junctions to the actin cytoskeleton, form a 
complex in cells grown in low calcium; upon initiation of junction formation, this ZO-1-α-catenin 
complex is recruited to forming junctions, coupling assembly of tight and adherens junctions (Fig. 
4A)109,110. A central coordinating role is also played by nectins, adherens junction adhesion proteins 
that participate in the recruitment of JAM-A111. JAM-A localizes first to nectin-based cell-cell 
contacts, which is dependent afadin forming a bridge between nectin and ZO-1, a JAM-A-binding 
protein. Formation of mature tight and adherens junctions then requires activation of multiple 
signalling mechanisms that include different PKCs, PKA, AMPK, protein phosphatases, and small 
and heterotrimeric GTPases (Table 1)43-­‐45,108,112.  
 Many tight junction proteins interact with the actin cytoskeleton. Although the importance of 
individual interactions is still poorly understood, regulation of cytoskeletal dynamics is essential for 
junction formation and function. For example, myosin light chain kinase, a regulator of actomyosin 
activity, stimulates increased intestinal paracellular permeability during inflammation, a process 
involving junctional remodelling and occludin internalization113. RhoGTPases are major regulators 
of the actin cytoskeleton and, consequently, play fundamental roles in the regulation of junction 
assembly and function.  The mechanisms that control RhoGTPase signalling have been intensively 
investigated during the last years, leading to the discovery of regulators that control specific 
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processes by guiding the activity of RhoA, Cdc42, and Rac43,45. This includes guanine nucleotide 
exchange factors (GEFs) for RhoA, p114RhoGEF/ ARHGEF18 and ARHGEF11, that are recruited 
to forming junctions by cingulin, JACOP, and ZO-1, respectively, to promote ROCK driven myosin 
activation and junction formation (Fig. 4A)114-116. Similarly, the Cdc42 GEF TUBA is recruited to 
tight junctions by ZO-1 and tricellulin and regulates the junctional actomyosin cytoskeleton117,118. 
How these different mechanisms are coordinated with each other and are integrated into the 
cellular signalling networks that guide cell behaviour is still poorly understood and remains to be 
investigated in more detail.  
 
Establishment of apical polarity 
 Establishment of tight junctions is intimately linked with the signalling mechanisms that drive 
epithelial polarization112,119. During the initial assembly of junctions, the adhesion protein JAM-A 
recruits the PAR3-PAR6-aPKC complex120,121; thereby establishing the forming border between the 
apical and lateral domains (Fig. 4A, Table 1). The PAR3-PAR6-aPKC complex is an evolutionarily 
conserved signalling module that drives apical polarization in response to Cdc42 activation. It is 
thought that early steps of junction formation are supported by the Cdc42 GEF ECT2 that 
associates with PAR3 and PAR6, and requires interplay with the GTPase activating proteins Rich1 
and SH3BP1 that complete the GTPase cycle122-­‐124.	  Once cells start to polarize, activation of Cdc42 
at the apical pole and the apical margin close to tight junctions is catalysed by the GEF Dbl3, which 
is recruited by another pro-apical signalling determinant, ezrin125. Apical Cdc42 activation then 
promotes aPKC activation, leading to phosphorylation and dissociation of PAR3 from the PAR6-
aPKC complex. The latter translocates to the differentiating apical membrane in a still poorly 
understood process, whereas PAR3 remains at tight junctions and marks the border between 
apical and lateral domains. This process is essential for the development of specialised apical 
membrane domains, such as the intestinal brush border membrane, and drives the accumulation 
of apical signalling proteins (e.g., Crb3) as well as proteins required for apical functions (e.g., brush 
border enzymes)125. This mechanism is evolutionarily conserved and linked to the subapical zone 
and adherens junctions in Drosophila (Box 1)126,127.	  
 A second pro-apical signalling complex also associates with tight junctions, the Crb3/Pals-
1/PATJ complex, which links to tight junctions via PATJ interacting with ZO-3, claudin-1 and JAM-
A128-130. Crb3 is a transmembrane protein that during apical differentiation is phosphorylated by 
aPKC, which involves an interaction with the PAR6131. Activation of pro-apical signalling does not 
only promote apical differentiation, it also leads to a suppression of pro-basolateral 
determinants119,132. Consequently, the extent of apical Cdc42 activation also determines the 
relative size of the two cell surface domains and, thereby, the positioning of the tight junction, the 
apical-lateral border125.  
 
Signalling from tight junctions  
 It has become apparent that tight junctions, apart from serving as permeability barriers, are also 
important signalling platforms. As discussed above, assembly of these junctions is inherently linked 
to the establishment of epithelial apicobasal polarity. Additionally, tight junctions transmit signals to 
the cell interior to regulate the cytoskeleton, gene expression, cell proliferation and differentiation 
during various cellular processes (Table1). These mechanisms have recently been reviewed and 
we will only summarize some of the central principles and recent developments43,44,112. 
 To start, tight junctions signal to guide cell proliferation and differentiation. Their formation 
accompanies the establishment of epithelial sheets with the increasing cell density inhibiting 
proliferation. This process includes well-known signalling mechanisms such as the Hippo pathway 
that regulates the transcriptional coactivators YAP and TAZ. Tight junction associated mechanisms 
that affect activity of these transcription factors includes both junctional recruitment of Hippo 
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pathway kinases that phosphorylate and inhibit them, the merlin tumour suppressor mechanism 
that links the Crb signalling complex to inhibition of proliferation, as well as interactions with 
junctional adaptor proteins such as angiomotin, ZO-2 and PAR3133-­‐138. Other proliferation-regulating 
transcription factors have been shown to localise to tight junctions as well as nuclei, such as 
ZONAB, a protein inhibited by ZO-1 binding that promotes proliferation and interacts with other 
proteins at cell junctions such as symplekin, RalA, GEF-H1 and CDK423,24,139-­‐142. As ZONAB binds 
multiple proteins at tight junctions, removal of ZO-1 alone may not be sufficient to lose junctional 
localisation as has recently been suggested28. The latter paper also concluded that ZO-1 does not 
bind ZONAB28. However, others who employed the same extraction conditions as originally 
described for the isolation of ZO-1/ZONAB complexes co-immunoprecipitated the two proteins 
successfully, and suggested a molecular and functional link with claudin-2143-­‐145. The ZO-1/ZONAB 
pathway is thought to regulate expression of ErbB2, cyclin D1 and PCNA23,146. This has recently 
been questioned as no effect on the expression of these genes was detected in MDCK cells 
constitutively depleted of ZO-1, ZO-2 and ZO-3 individually or together28. However, these assays 
were performed in low density, proliferating cells in which ZONAB is fully active and not inhibited 
by ZO-1 (even overexpression of ZONAB does not stimulate proliferation in such cells)139. Recent 
studies linked the ZO-1/ZONAB pathway to distinct regulatory mechanisms. CFTR, the 
transmembrane protein linked to cystic fibrosis, binds and stabilises ZO-1, leading to reduced ZO-1 
expression in its absence and, thereby, promoting nuclear translocation of ZONAB, induction of 
cyclin D1 and repression of ErbB2147. Manipulation of other junctional transmembrane proteins, 
such as BVES, regulates ZONAB activation via a GEF-H1/RhoA-stimulated mechanism140,148. In 
endothelial cells of the blood-tumour-barrier, bradykinin-induced activation of nitric oxide synthesis 
induces increased permeability and ZONAB activation, leading to repression of claudin-5 and 
occludin promoters149. The group of dual localization proteins associated with tight junctions also 
includes junctional adaptors such as ZO-2, which travels to the nucleus at low cell density and 
interacts with several transcription factors including c-Myc, AP-1 and YAP, regulators of cell 
proliferation44. Depletion of ZO-2 in MDCK cells induces cell size increases and enhanced cyclin 
D1 expression due to modulation of the YAP and Akt/mTOR pathways150.	   
 Tight junctions can also signal to the cell interior via classical signalling cascades, such as the 
JNK1/2 mitogen activated protein kinase pathway that is regulated via an interaction between the 
membrane protein MarvelD3 and MEKK1 (MAP3K1)41. This pathway regulates epithelial cell 
proliferation and migration with MarvelD3 functioning as a dynamic attenuator that recycles 
between tight junctions and endosomes. Occludin, a close relative of MarvelD3, also interacts with 
a mitogen activated protein (MAP) kinase pathway, but suppresses dissociation of cell junctions by 
Raf-1 activated Erk signalling via unknown mechanisms151. Occludin interacts with multiple 
signalling proteins that may play a role and has also been linked to TGFβ-induced junction 
dissociation (Table 1)42,152,153.  
 Signalling at tight junctions seems to play an important role in the cellular stress response, and 
ZO proteins have been linked to junctional integrity in response to stress in zebrafish and C. 
elegans, possibly due to regulating F-actin remodelling51,154. Junctional processes also affect 
general cell behaviour during stress, such as the above-described MarvelD3-MEKK1-JNK1/2 
pathway, which is important for cell survival during hyperosmotic stress. Similarly, stress-induced 
Erk activation stimulates the GEF-H1/ZONAB pathway to regulate gene expression 
posttranscriptionally as part of a Ras effector pathway that regulates cell survival142,155. In response 
to heat shock, ZONAB is activated by Apg-2, a heat shock protein that competes for ZONAB 
binding to ZO-124. Hence, tight junctions appear to function as sensors for cell stress and are 
components of MAP kinase signalling networks that can regulate MAP kinase activation as well as 
transmit MAP kinase signals. 
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Crosstalk with other adhesion complexes  
  While different adhesion complexes that mediate interactions with neighbouring cells and the 
cell matrix are often considered in isolation, they influence each other strongly. As we discussed 
above for junction assembly, such crosstalk can involve formation of complexes containing 
components of different adhesion complexes. However, it can also involve regulation of signalling 
pathways (Fig. 4B). For example, JAM-A-mediated cell-cell adhesion signals via two related small 
GTPases of the Ras-related protein family: Rap1 and Rap2. JAM-A stimulated Rap2 activation 
promotes stabilisation of adherens junctions;	  and activation of Rap1 affects adhesion to 
extracellular matrix and cell migration by regulating integrin β1 expression and recycling156-­‐159. In 
endothelial cells, ZO-1 regulates overall cell-cell tension as well as tensile forces acting on 
adherens junctions by regulating recruitment of a complex formed by p114RhoGEF and JACOP, 
which stimulates junctional RhoA/ROCKII/myosin activation116. Loss of ZO-1 also promotes 
formation of stress fibres and focal adhesions indicating that signalling at tight junctions has cell-
wide consequences on the cytoskeleton and adhesion. Orchestration of cell-cell tension and focal 
adhesion formation by ZO-1 is functionally important for the regulation of cell migration and 
angiogenesis. Stress fibre formation and focal adhesion formation also depends on GEF-H1, which 
stimulates RhoA along the basal membrane and drives focal adhesion formation in various cell 
types. GEF-H1 is recruited to tight junctions by cingulin, which then leads to inhibition of the GEF, 
similar to the inhibition of this GEF by binding to microtubules (Table 1)160-165. While a role for ZO-1 
in suppressing focal adhesion formation has so far only been demonstrated in endothelial cells, 
disruption of tight junction formation and stress fibre formation by depletion of p114RhoGEF, a 
GEF that supports junction formation, occurs in endothelial and epithelial cells114.  
 Similar to crosstalk with adherens junctions, crosstalk between focal adhesions and tight 
junctions is not limited to signalling but may also involves complex formation between focal 
adhesion and tight junction proteins. For example, some claudins and JAM-A have been shown to 
associate with integrin complexes and/or to regulate cell migration166-­‐170, however, it is not known 
whether such observations reflect independent roles or is yet another example of a regulatory link 
between tight junctions and focal adhesions. 
  
Conclusions and perspectives  
 Despite significant recent progress in structural and functional analysis of tight junctions, many 
open questions still remain. First of all, the topology of the adhering plasma membranes remains to 
be determined, and a structural model needs to be developed that explains how different junctional 
transmembrane proteins that have different dynamic properties can mix in the same branched 
intramembrane strand network and at the same time form intercellular protein complexes serving 
as paracellular ion-selective pores and a lipid diffusion fence. Another longstanding problem is the 
molecular mechanism that enables size-selective macromolecular paracellular diffusion. While the 
current data regarding different junctional components and their reaction to physiological stimuli 
would be compatible with a model based on a dynamic, remodelling strand network, the methods 
to visualize strand dynamics still need to be developed to validate this model. Furthermore, despite 
the fact that a wealth of exciting data has been generated linking particular junctional proteins to 
specific junctional barrier or junctional functions, it is still poorly understood how different proteins 
cooperate to regulate such functions, how the junctional protein network adapts to removal of 
specific components, and how such modified junctions respond to different physiological and 
pathological stimuli. Tight junction-associated signalling mechanisms have now been firmly linked 
to the regulation of cell proliferation, polarization and differentiation, and many of these 
mechanisms are evolutionarily conserved even if they might be associated with a different type of 
junction in different phyla. Nevertheless, we still need to establish how exactly signalling initiated at 
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junctions integrates into complex signalling pathways driving diverse cellular processes. Finally, 
the analysis of the mechanisms by which different adhesion complexes that mediate cell-cell and 
cell-matrix interactions communicate and cooperate with each other will likely lead to exciting new 
insights into the processes that mediate epithelial and endothelial tissue development and function. 
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Online summary 
 
- Tight junctions are intercellular adhesion complex in epithelia and endothelia that control 
paracellular permeability. This paracellular diffusion barrier is semipermeable as it is size- and 
charge-selective. 
 
- Paracellular ion permeability is largely determined by the claudin composition of tight junctions, a 
family of transmembrane proteins that are thought to form gated ion-selective paracellular pores 
through the paracellular diffusion barrier. 
 
- Tight junctions form the border between the apical and basolateral cell surface domains in 
polarized epithelia, and support the maintenance of cell surface polarity by restricting intermixing of 
apical and basolateral transmembrane components. 
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- Tight junctions are an integral component of the evolutionarily conserved signalling mechanisms 
that control epithelial cell polarization and the formation of morphologically and functionally distinct 
apical domains. 
 
- Tight junctions form bidirectional signalling platforms that receive signals from the cell interior 
regulate their assembly and function, and that transduce signals to the cell interior to control cell 
proliferation, migration, differentiation and survival. 
 
- Tight junctions are part of an interconnected network of adhesion complexes that includes 
adherens junctions and focal adhesions. These adhesion complexes crosstalk via direct protein-
protein interactions as well as by transmitting signals to each other that influence their assembly 
and function. 
 
Glossary 
Actomyosin - cytoskeletal fibres formed by F-actin and myosin II. 
Desmosomes - an adhesive structure, also known as maculae adherents, formed from dense 
protein plaques of two adjacent cells, with associated intermediate filaments and transmembrane 
proteins known as cadherins. 
Immunoglobulin-like domain - a protein domain consisting of a double layer sandwich of 7-9 
antiparallel β-stands arranged in two β-sheets. 
Osmoregulation - a process utilized by cells and simple organisms to maintain fluid and 
electrolyte balance with their immediate environment. 
Lipid Micelles - lipid molecules arranged in a spherical form in aqueaous solutions in response to 
the amphipathic nature of fatty acids, i.e. containing both a hydrophilic, polar head group and a 
long hydrophilic chain.  
Patch clamp approach - an electrophysiology technique that allows the study of single and 
multiple ion channels in membranes. 
Homology Model - a comparative modelling of a protein through construction of an atomic 
resolution model of the ‘test’ protein from its amino acid sequence and a resolved three-
dimensional structure of a related homologous protein ‘used’ as a template. 
Guanine nucleotide exchange factor (GEF) - proteins that activate monomeric GTPases by 
stimulating the dissociation of guanosine diphosphate (GDP), thereby permitting binding of 
guanosine triphosphate (GTP). 
Small GTPase - small monomeric proteins homologous to Ras that exist in an inactive GDP-bound 
form and an active GTP-bound form in which they activate other signalling proteins. 
Heterotrimeric GTPase - also called G-proteins and consist of three subunits: the GTP-binding α 
subunit and the smaller β and γ subunits that have regulatory and signalling functions. 
Hyperosmotic stress - a phenomenon experienced by cells and tissues when extracellular fluid 
osmolarity exceeds that of the intracellular fluid. 
Focal Adhesions - large dynamic protein complexes that link the cytoskeleton of a cell to the 
extracellular matrix (ECM). 
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Stress fibres - contractile actin bundles in non-muscle cells comprising of actin microfilaments, 
myosin II and crosslinkers such as α-actinin.  
MARVEL Domain - a four transmembrane helix module that has been identified in proteins of 
various families, many of which associated with cholesterol-rich membrane microdomains. 
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Figure Legends 
Figure 1. The junctional complex and tight junctions.  
(A) The junctional complex in epithelial and endothelial cells. Tight junctions (orange) are apically 
located in polarised epithelial cells and often intermixed with adherens junctions (green) in 
endothelial cells. (B) Brief overview of the types of tight junction proteins: transmembrane and 
cytoplasmic plaque proteins. Indicted are only representatives of the main groups of tight junction 
proteins: transmembrane proteins (Crb3; Marvel domain proteins like occludin, tricellulin, and 
MarvelD3; claudins; JAMs; BVES), adaptor proteins and cytoskeletal linkers (zonula occludens ZO 
proteins, cingulin, Pals-1, PATJ, MAGI, PAR3 and PAR6), and signalling components (aPKC; the 
small RhoGTPases Cdc42, Rac and RhoA; and guanine nucleotide exchange factors for Rho 
GTPases). Indicated are also the adherens junction complexes based on E-cadherin and nectin 
and their main cytosolic interaction partners (E-cadherin: p120catenin, α- and β-catenin; nectins: 
AF-6) that are mentioned in this review. (C) Super-resolution immunofluorescence image of the 
tight junction cytoplasmic plaque proteins ZO-1 and cingulin illustrating the apparently ordered, 
regular structure of the junctional plaque (shown is an image of renal epithelial cells obtained with 
a gated stimulated emission depletion microscope. (D) Scheme of areas of apparent hemifusions 
of neighbouring cells where tight junction strands are located. (E) A freeze fracture electron 
microscopy image of the tight junction strand network along the apical membrane domain of 
intestinal epithelial cells (Image, Peter Munro).  
 
Figure 2. Tight Junctions structure and function working models.  
(A) Models of tight junction. The protein model relies on intercellular protein-protein interactions for 
the formation of a paracellular diffusion barrier between two plasma membranes formed by 
standard lipid bilayers. In the lipid-protein hybrid model, the continuity of the lipid bilayer is 
interrupted by cylinder-shaped inverted micelles that allow areas of hemifusions of the two 
neighbouring plasma membranes that are stabilised by transmembrane proteins. In such a model, 
the exoplasmic leaflets of neighbouring cells are continuous. (B) The fence and gate functions. 
Integral transmembrane protein components are shown to act as a fence for diffusion of lipids 
along the exoplasmic leaflet; in a hybrid model, the contact site would also contain inverted 
micelles. Indicated is also the gate function, which refers to a regulated semipermeable diffusion 
barrier that controls diffusion along the paracellular space. (C, D) Specificity of the paracellular 
gate and mechanisms of diffusion. The paracellular diffusion barrier is semipermeable and 
differentiates solutes on the basis of size and charge. Size-selective macromolecular diffusion of 
tracers (green particles, hydrophilic molecules that can diffuse across the junction; red particles, 
molecules too large to cross tight junctions) and ion conductance are though to be mediated by two 
distinct mechanisms. Ion conductance is mediated by gated channels that can be open or closed 
and are ion-selective. These channels are formed by intercellular claudin complexes forming a 
pore-like structure (see figure 4). Size-selective macromolecular tracer diffusion is less well 
understood but may involve dynamic properties of the intramembrane strands such as remodelling 
of the branches or even dissociation/reformation of strand sections, leading to transient openings 
to allow the stepwise diffusion across the junction (depicted in panel D, which represents a 
schematic en face view of a section through tight junctions along the contacts between two 
neighbouring cells). The indicated serial diffusion barriers are thought to be represented by the 
intramembrane strands seen in freeze fracture replicas. 
 
Figure 3. Structure of claudins and intercellular pore formation.  
(A) Scheme of claudin structure and motifs. The crystal structure of claudin-15 has revealed a 
characteristic β-sheet fold of the two extracellular domains that is anchored to a transmembrane 
four-helix bundle (TM 1-4). The two extracellular domains or ‘loops’ (ECL1 and ECL2) are 
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important for ion-selectivity of the paracellular pathway due to specific correspondingly charged 
residues (e.g., claudin-15 has negatively charged residues and forms a cation-selective pore). (B, 
C) Claudins are thought to dimerise face-to-face through interactions between the edges of the 
extracellular β-sheets as well as to interact with neighbouring claudin molecules within the same 
plasma membrane (here annotated as protein 1 (P1) and protein 2 (P2)). Three of the 
transmembrane domains (TM1, 2 and 4; orange) have the exact length required to span a lipid 
bilayer; the third transmembrane domain is longer (blue) and it is thought that the extended 
hydrophobic domain is important for the interaction with the adjacent protomer. The two indicated 
cysteins in the extracellular loop 1 (ECL1) form a disulphide bond that is structurally essential. V1 
and V2 refer to variable, flexible regions that may be important for the specificity of interactions 
between claudins of neighbouring cells (cell-cell interaction). (B, C) The interactions between 
claudin molecules in cis (i.e., within the same membrane) and in trans (i.e., with molecules in the 
neighbouring membrane) is thought to result in the formation of two anti-parallel claudin polymers 
in each membrane and are proposed to represent the intramembrane strands seen in freeze 
facture replicas. The two sets of anti-parallel strands form intercellular adhesions by face-to-face 
interactions of claudin molecules, protomers, resulting in the formation of paracellular pores. These 
paracellular pores are gated (i.e., they can be either opened or closed); however, the structural 
changes underlying gating are not known.   
 
Figure 4. Junction assembly and crosstalk between adhesion complexes. 
(A) Epithelial cells form cell-cell junctions by assembling a primordial junction initiated by E-
cadherin and nectin, leading to the recruitment of tight junction components due to interactions 
between bona fide tight and adherens junction components such as ZO-1 and α-catenin. 
Subsequent increases in recruitment of tight junction proteins and signalling proteins such guanine 
nucleotide exchange factors that activate signalling by RhoA and Cdc42 induces junctional 
maturation, which involves the formation of distinct tight and adherens junctions, and a junctional 
enrichment of the actomyosin cytoskeleton. Myosin activation promotes the development of regular 
epithelial cell shapes (e.g., columnar epithelia such as those in the intestinal tract. Finally, 
polarisation is then induced by polar activation of Cdc42 along the apical domain and at the 
marginal zone close to tight junctions. Active Cdc42 binds to the PAR3-PAR6-aPKC complex, 
leading to activation of the kinase, and induces development of a polarized cell surface with a well-
differentiated apical cell membrane (e.g., a brush border membrane in intestinal and many other 
epithelial cells). (B) Complexes involved in cell adhesion are signal hubs that send and receive 
signals that guide cell behaviour, function and morphogenesis; extensive crosstalk exists between 
different adhesion complexes. For example, JAMs are recruited by forming adherens junction via 
interactions mediated by the tight junction protein ZO-1 and the nectin binding protein AF-6. This 
then leads to the increased recruitment of other junctional proteins and activation of two small 
GTPases, Rap1 and Rap2, that regulate the functions of integrin-based focal adhesions and of 
adherens junctions. Forming tight junctions also recruit activators of Rho GTPases, guanine 
nucleotide exchange factors like GEF-H1, which is inactive at junctions, and p114RhoGEF 
(p114RG), which drives junctional RhoA activation, due to interactions with junctional adaptor 
complexes formed by cingulin and JACOP, which are recruited by ZO-1. Tight junction dissociation 
triggers the release of GEF-H1 leading to RhoA activation along the base of the cells. This 
stimulates the induction of stress fibres and increased focal adhesion formation including the 
recruitment of proteins that regulate focal adhesions such as focal adhesion kinase (FAK). In 
endothelial cells, ZO-1 coordinates junctional actomyosin activity leading to increased cell-cell 
tension and pulling on cadherin-based adherens junctions via a molecular bridge between the 
actomyosin cytoskeleton and the cadherin formed by α- and β-catenin, as well as vinculin. Vinculin 
can be recruited to both adherens junction, by interaction with α-catenin, and focal adhesions, by 
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interaction with talin and α-actinin, which is regulated by cytoskeletal tension pulling on an 
adhesion complex. Claudin-7 and -11 have been reported to form complexes with integrins and 
regulate migration; however, it is not yet clear whether this indeed represents crosstalk between 
tight junctions and focal adhesions, or occurs independently of tight junctions. 
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Table 1 – Signalling to and from tight junctions 
 
Signalling to tight junctions: Regulation of junction assembly and function 
 -  JAMA – PAR3/PAR6/aPKC; initiation of junction assembly  
- Crb3 – Pals1, PATJ, ZO-3 – aPKC; junction assembly and initiation of polarisation 
- Tricellulin, ZO-1 – TUBA; stimulation of Cdc42/N-WASP regulated F-actin organisation 
- JAMA, ZO-1, JACOP (Paracingulin)  – p114RhoGEF; regulation of RhoA/ROCKII/myosinII and        
endothelial cell-cell tension 
- ZO-1  –  ARHGEF11; stimulation of RhoA and myosinII activation 
- Cingulin, PATJ  –  p114RhoGEF; stimulation of RhoA/ROCKII/myosinII, regulated by Lulu2 
- PAR3, PAR6  –  ECT2; activation of Cdc42/aPKC signalling 
- JACOP (Paracingulin)  –  SH3BP1; negative regulation of Cdc42, regulation of actin remodelling 
- Angiomotin  –  RICH1; negative regulation of Cdc42 
- ZO-1  –  heterotrimeric G proteins (e.g., Gαi2); regulation of junction assembly 
-  aPKC, PP2A; regulation of TJ protein phosphorylation 
-  WNK1/4  –  Claudins; regulation of paracellular ion conductance 
-  AMP-activated Kinase (stimulated by LKB1 and Calmodulin activated Kinase II); stimulation of 
junction assembly, phosphorylation of claudins and cingulin 
-  classical and novel PKCs and PKA; stimulation of junctional cytoskeleton, assembly and 
function 
 
 
Signalling from tight junctions: Cell behaviour, survival and differentiation 
- Crb3, Pals1, PAR6, PAR3 – aPKC; apical differentiation 
- MARVELD3  –  MEKK1; regulation of JNK signalling, gene expression and stress response 
- Occludin  –  c-yes, Raf-1 kinase, PI3 Kinase, TGFβR1, c-src, E3 ubiquitin-protein   
     ligase Itch; regulation of cell transformation and junction dissociation 
-   JAM-A, tetraspanin (CD9)/integrin complexes; angiogenic signalling and migration 
-   Ezrin  –  Dbl3 and Cdc42; apical differentiation 
-   Cingulin, Jacob (paracingulin)  –  GEF-H1; downregulation of cytoplasmic RhoA signalling and  
 stress fibres 
-   ZO-1 –  ZONAB/symplekin/CDK4, GEF-H1, Apg-2; transcriptional and posttranscriptional  
    regulation of gene expression, proliferation, stress response and survival 
-   ZO-2  –  c-Myc, SAFB, AP-1; regulation of gene expression and proliferation 
-   Merlin, Angiomotin, PAR3, Mst, LATS, ZO-1/2  –  YAP and TAZ; regulation of gene expression   
    and proliferation 
-   Angiomotin  –  RICH1; regulation of Rac-activated MAP kinase signalling 
-   PATJ  –  Tsc2; regulation of mTORC1 activity 
-   MAGI1/2/3  –  PTEN; regulation of Akt and cell survival signalling 
 
 
Tight junctions are connected to the main cellular signalling networks that guide cell shape and 
junction assembly, transcriptional and posttranscriptional gene expression, and cell proliferation 
and differentiation. These signalling mechanisms transmit information in two directions: Form the 
cell interior to the junction to guide junction assembly and function, and from the junction to the cell 
to guide gene expression, proliferation, and differentiation. Summarised are the main signalling 
mechanisms linked to TJ and their main components. Adaptor proteins are blue, transmembrane 
proteins brown, and signalling proteins red. The hyphen refers to regulatory links that are generally 
mediated by direct protein/protein interactions.  
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Box 1 - Evolutionary conservation of tight junction functions 
  
 Occluding junctions show a higher degree of variation in metazoans than cadherin-based 
junctions. In vertebrates, tight junctions are located apical to adherens junctions, whereas in 
invertebrates the most apical junctional structures are commonly adherens junctions. Although 
tight junction structures exist in some lower invertebrates and chordates, the equivalent structure in 
many invertebrate epithelia is located basal to the adherens junction, and is known as septate 
junction (e.g., insects), or the diffusion barrier may be part of adherens junctions (e.g., C. elegans) 
171,172.  The septate junction in Drosophila contains claudin-like molecules that are important for 
barrier function173-177. C. elegans also expresses claudin-like molecules, and at least two of them 
are important for barrier formation; however, they are associated with adherens junctions178. Thus, 
the importance of claudins for barrier formation is conserved, the junction they associate with is 
not. 
 Another striking example of evolutionary conservation is the machinery associated with apical 
polarization. Tight junctions form the apical/lateral border in vertebrates whereas this border is 
associated with adherens junctions in invertebrates. Just apical to the apical/lateral border is a 
specialized signalling zone, the subapical region (SAR; also known as apical marginal zone) that 
was first identified in Drosophila. The signalling mechanisms that regulate apical polarization 
include two protein complexes formed by apical determinants: the PAR-3/PAR-6/aPKC/Cdc-42 and 
the Crb3/Pals1/PATJ complexes. Both complexes have been reported to associate with tight 
junctions in vertebrates and have homologs in C. elegans and Drosophila, where they associate 
with the SAR179. The evolutionary conservation may even extend further as a SAR-like signalling 
zone enriched in aPKC, Crb3, ezrin and the Cdc42 activator Dbl3 is also associated with the apical 
end of tight junctions in vertebrates125.  
 Different junctional functions are thus associated with different types of junctions in different 
phyla, suggesting that intercellular junctions have become reconfigured during evolution but that 
individual processes are conserved. This is also reflected in the molecular remodelling that occurs 
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during junction assembly: an initial primordial adhesive complex contains components of tight 
junctions and adherens junctions, and then matures into distinct junctional complexes180.  
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Box 2 - Tight junctions and molecular links to human disease 
 
Linked to inherited genetic diseases and single nucleotide polymorphisms  
Transmembrane proteins 
Claudin-1  –  Neonatal ichtyosis and sclerosing cholangitis 
Claudin-5 (TMVCF) –  Velo-cardial-facial syndrome 
Claudin-14 –  Non-syndromic deafness 
Clauidn-16 (paracellin-1) –  Familial hypomagnesemia, hypercalciuria, nephrocalcinosis 
Clauidn-19 –  Familial hypomagnesemia, hypercalciuria, nephrocalcinosis, visual 
impairment 
Tricellulin –  Non-syndromic deafness  
Adaptor protein 
ZO-2 –  Familial hypocholamenia 
Signalling proteins 
p114RhoGEF –  Systemic Capillary Leak Syndrome (Clarkson disease) 
ZONAB –  Activated in cystic fibrosis due to downregulation of ZO-1, a binding 
partner of CFTR (cystic fibrosis transmembrane conductance 
regulator) 
WNK4 - Pseudohypoaldosteronism type II, a kinase that phosphorylates 
claudins 
 
Tight junction components targeted by pathogenic viruses and bacteria 
Transmembrane proteins 
Claudin-1/6/9; occludin – Hepatitis C virus, infection 
JAM-A – Reovirus, infection 
CAR – Coxsackie virus, infection 
Claudin-3/4 – Clostridium, junction dissociation 
Occludin – V. cholera, junction dissociation 
Adaptor proteins 
ZO-1, ZO-2 – Tick-borne encephalitis and Dengue viruses  
ZO-2, MUPP1, PATJ, – Adenovirus 
MAGI1 
MAGI1-3, PATJ, – Papillomaviruses, papilloma formation 
MUPP1, PAR3 
MAGI1-3 – Influenza A virus, junction dissociation 
Pals1 – Severe acute respiratory syndrome virus, retarded junction formation  
Signalling proteins 
GEF-H1 – H. pylori via PAR1, junction dissociation, leads to displacement of 
 structural junctional proteins like ZO-1 and occludin 
 
TJs have been linked to diseases that affect many tissues and organs. Some of these diseases are 
inherited and involve mutations or polymorphisms in TJ-associated proteins themselves or lead to 
activation of TJ-associated signalling mechanisms as in the case of cystic fibrosis. Similarly, 
multiple pathogenic viruses and bacteria are known to target TJ. Usually, this involves direct 
interactions with junctional proteins but, as in the case of H. pylori, may involve activation of a 
cellular signalling protein that is not associated with TJ, PAR1, that then stimulates a junctional 
signalling pathway. Many other diseases such as chronic inflammatory conditions and cancer have 
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been linked to TJ but it is generally not known whether TJ deregulation is a cause or consequence 
of disease. For more details, see 43,85. 
 
 
